BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 15324403)

  • 41. Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma.
    Technau K; Renkl A; Norgauer J; Ziemer M
    Eur J Dermatol; 2005; 15(2):110-2. PubMed ID: 15757825
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glucagonoma syndrome with necrolytic migratory erythema as initial manifestation.
    Zhu WF; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2021 Dec; 20(6):598-600. PubMed ID: 34544669
    [No Abstract]   [Full Text] [Related]  

  • 43. [Glucagonoma revealed by necrolytic migratory erythema].
    Bonaventure C; Merle P; Grezard P; Ruiz JM; Chevallier M; Scoazec JY; Trepo C
    Gastroenterol Clin Biol; 2003 Feb; 27(2):230-2. PubMed ID: 12658134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Necrolytic migratory erythema as the only presenting sign of a glucagonoma.
    Johnson SM; Smoller BR; Lamps LW; Horn TD
    J Am Acad Dermatol; 2003 Aug; 49(2):325-8. PubMed ID: 12894090
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The glucagonoma syndrome and necrolytic migratory erythema: a clinical review.
    van Beek AP; de Haas ER; van Vloten WA; Lips CJ; Roijers JF; Canninga-van Dijk MR
    Eur J Endocrinol; 2004 Nov; 151(5):531-7. PubMed ID: 15538929
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glucagonoma-Associated Necrolytic Migratory Erythema: The Broad Spectrum of the Clinical and Histopathological Findings and Clues to the Diagnosis.
    Toberer F; Hartschuh W; Wiedemeyer K
    Am J Dermatopathol; 2019 Mar; 41(3):e29-e32. PubMed ID: 30124507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Papulosquamous eruption with weight loss: Necrolytic migratory erythema (glucagonoma syndrome).
    Skouge JW; Farmer ER
    Arch Dermatol; 1985 Mar; 121(3):400, 403. PubMed ID: 2983618
    [No Abstract]   [Full Text] [Related]  

  • 48. Necrolytic Migratory Erythema: Complete Healing after Surgical Removal of Pancreatic Carcinoma.
    V'lckova-Laskoska M; Balabanova-Stefanova M; Arsovska-Bezhoska I; Caca-Biljanovska N; Laskoski D
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):329-332. PubMed ID: 30665484
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Necrolytic migratory erythema is an important visual cutaneous clue of glucagonoma.
    Li W; Yang X; Deng Y; Jiang Y; Xu G; Li E; Wu Y; Ren J; Ma Z; Dong S; Han L; Ma Q; Wu Z; Wang Z
    Sci Rep; 2022 May; 12(1):9053. PubMed ID: 35641533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Necrolytic migratory erythema: A diagnostic clue in glucagonoma syndrome.
    Moreno-Suárez F; Pulpillo-Ruiz Á; Fontillón Alberdi M
    Med Clin (Barc); 2017 Apr; 148(8):e45. PubMed ID: 27567335
    [No Abstract]   [Full Text] [Related]  

  • 51. [Necrolytic cutaneous erythema and pancreatic tumour: the glucagonoma].
    Drematcheff S; Champetier de Ribes TL; Marty C; Sans N; Railhac JJ
    J Radiol; 2004 Mar; 85(3):329-31. PubMed ID: 15192527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Necrolytic migratory erythema: unresolved problems in diagnosis and pathogenesis. A case report and literature review.
    Kasper CS
    Cutis; 1992 Feb; 49(2):120-2, 125-8. PubMed ID: 1563284
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Images in clinical medicine. Necrolytic migratory erythema.
    McGevna L; Tavakkol Z
    N Engl J Med; 2010 Jan; 362(1):e1. PubMed ID: 20054043
    [No Abstract]   [Full Text] [Related]  

  • 54. Necrolytic migratory erythema: a common cutaneous clue of uncommon syndromes.
    Stavropoulos PG; Papafragkaki DK; Avgerinou G; Papafragkakis H; Katsavou A; Katsambas AD
    Cutis; 2013 Nov; 92(5):E1-4. PubMed ID: 24343217
    [No Abstract]   [Full Text] [Related]  

  • 55. Normoglycemic glucagonoma syndrome associated with necrolytic migratory erythema.
    Feldmann R; Wahl S; Steiner A
    J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):e306-e307. PubMed ID: 29419911
    [No Abstract]   [Full Text] [Related]  

  • 56. Glucagonoma syndrome: survival 24 years following diagnosis.
    Nightingale KJ; Davies MG; Kingsnorth AN
    Dig Surg; 1999; 16(1):68-71. PubMed ID: 9949270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Necrolytic migratory erythema in a patient with a glucagonoma].
    Demirbas M; Prens B
    Ned Tijdschr Geneeskd; 2021 Oct; 165():. PubMed ID: 34854628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Necrolytic migratory erythema associated with glucagonoma syndrome: a case report.
    Dal Coleto CC; de Mello AP; Piquero-Casals J; Lima FR; Vilela MA; Festa-Neto C; Sanches JA
    Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(6):183-8. PubMed ID: 11836542
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Necrolytic Migratory Erythema Associated with a Glucagonoma.
    Banerjee A; Shah SR
    N Engl J Med; 2020 Aug; 383(6):e39. PubMed ID: 32757527
    [No Abstract]   [Full Text] [Related]  

  • 60. Necrolytic migratory erythema with recalcitrant dermatitis as the only presenting symptom.
    Garner R; Ahern K; Poligone B
    Cutis; 2016 Jun; 97(6):E6-7. PubMed ID: 27416097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.